These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36693834)

  • 1. Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma.
    Wei L; Ma X; Hou Y; Zhao T; Sun R; Qiu C; Liu Y; Qiu Z; Liu Z; Jiang J
    Cell Death Discov; 2023 Jan; 9(1):30. PubMed ID: 36693834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
    Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
    Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.
    Wang C; Jeong K; Jiang H; Guo W; Gu C; Lu Y; Liang J
    Am J Cancer Res; 2016; 6(5):996-1010. PubMed ID: 27293994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic Perspectives.
    Simula L; Alifano M; Icard P
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma.
    Zhou Q; Li W; Kong D; Liu Z; Shi Z; Ma X; Li Y; Jiang J
    Cancer Med; 2019 Aug; 8(9):4380-4388. PubMed ID: 31215145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts.
    Gao N; Lu L; Ma X; Liu Z; Yang S; Han G
    Exp Dermatol; 2022 Mar; 31(3):320-329. PubMed ID: 34623712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
    Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
    Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotective effects of Insulin-Like Growth Factor 1 via the Hippo/YAP signaling pathway are mediated by the PI3K/AKT cascade following cerebral ischemia/reperfusion injury.
    Gong P; Zou Y; Zhang W; Tian Q; Han S; Xu Z; Chen Q; Wang X; Li M
    Brain Res Bull; 2021 Dec; 177():373-387. PubMed ID: 34717965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous knockdown of YAP and TAZ increases apoptosis of hepatocellular carcinoma cells under hypoxic condition.
    Yan B; Li T; Shen L; Zhou Z; Liu X; Wang X; Sun X
    Biochem Biophys Res Commun; 2019 Jul; 515(2):275-281. PubMed ID: 31146919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway.
    Fu J; Zheng M; Zhang X; Zhang Y; Chen Y; Li H; Wang X; Zhang J
    Biochem Biophys Res Commun; 2017 Nov; 493(2):985-991. PubMed ID: 28942149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y; Tong J; Ai Z; Wang J; Teng Y
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
    Khanal P; Yeung B; Zhao Y; Yang X
    Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
    Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
    Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy.
    Liu H; Zhang L; Zhang X; Cui Z
    Onco Targets Ther; 2017; 10():2865-2871. PubMed ID: 28652768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy.
    Thompson BJ
    Bioessays; 2020 May; 42(5):e1900162. PubMed ID: 32128850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond.
    Pontes B; Mendes FA
    Diseases; 2023 Jun; 11(2):. PubMed ID: 37366874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.
    Corvaisier M; Bauzone M; Corfiotti F; Renaud F; El Amrani M; Monté D; Truant S; Leteurtre E; Formstecher P; Van Seuningen I; Gespach C; Huet G
    Oncotarget; 2016 Aug; 7(35):56699-56712. PubMed ID: 27527859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TAZ impairs the migration ability of melanoma cells.
    Zhang H; Tu L; Ma Z; Lin Y; Tan Q
    Open Life Sci; 2023; 18(1):20220633. PubMed ID: 37360787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
    Budel SJ; Penning MM; Penning LC
    Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.